Apollo Endosurgery (APEN) Reports Q4 Loss of $35.01/Share

Apollo Endosurgery (NASDAQ: APEN) reported Q4 EPS of ($35.01), versus ($23.98) reported last year. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $8.16 million.

• Total revenue of $15.4 million
• Endo-bariatric sales of $7.6 million, up 26% year-over-year, including 9% growth in the U.S. and 50% international growth
• Completed reverse-merger with LPATH, Inc. (\"Lpath\"), raising $29.0 million; began trading on NASDAQ Global Market

For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Is Treasury selloff a major issue for stock market bulls?